Data / Drug companies / Folic acid
Folic acid: 34 companies and 58 products in the FDA NDC directory
Folic acid is listed in the FDA National Drug Code Directory by 34 companies, with 58 products in commercial distribution. 56 of the products (96.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; injection, solution; solution, and the newest product started marketing on September 16, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 34
- Products
- 58
- Generic (ANDA) products
- 56 (96.6%)
- Application numbers
- 10
- Routes
- Oral, Intramuscular, Intravenous, Subcutaneous
- Brand names
- Quiofic
- openFDA record search
- api.fda.gov
Companies that list folic acid
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aphena Pharma Solutions - Tennessee, LLC | 6 | tablet | Generic drugs (ANDA) | May 30, 2019 |
| Bryant Ranch Prepack | 6 | tablet | Generic drugs (ANDA) | October 25, 2022 |
| A-S Medication Solutions | 4 | tablet | Generic drugs (ANDA) | October 25, 2022 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | July 10, 2023 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet | Generic drugs (ANDA) | October 25, 2022 |
| Remedyrepack Inc. | 3 | tablet | Generic drugs (ANDA) | September 16, 2026 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | February 9, 2018 |
| Cardinal Health 107, LLC | 2 | tablet | Generic drugs (ANDA) | May 25, 2022 |
| Coupler LLC | 2 | tablet | Generic drugs (ANDA) | June 15, 2026 |
| Preferred Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | February 13, 2025 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | July 15, 2022 |
| Amneal Pharmaceuticals LLC | 1 | tablet | Generic drugs (ANDA) | December 2, 2009 |
| Amneal Pharmaceuticals of New York LLC | 1 | tablet | Generic drugs (ANDA) | March 7, 2022 |
| Ayurax, LLC | 1 | solution | Authorized generics (NDA) | January 28, 2026 |
| Cadila Pharmaceuticals Limited | 1 | tablet | Generic drugs (ANDA) | November 20, 2018 |
| Chartwell RX, LLC | 1 | tablet | Generic drugs (ANDA) | May 30, 2019 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | April 12, 2021 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | September 5, 2000 |
| Leading Pharma, LLC | 1 | tablet | Generic drugs (ANDA) | January 12, 2009 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | March 7, 2022 |
| Method Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | February 9, 2018 |
| Modavar Pharmaceuticals LLC | 1 | tablet | Generic drugs (ANDA) | November 20, 2018 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet | Generic drugs (ANDA) | July 10, 2023 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | August 15, 2023 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | January 12, 2009 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | August 4, 2015 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | February 9, 2018 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | January 12, 2009 |
| Quagen Pharmaceuticals LLC | 1 | tablet | Generic drugs (ANDA) | July 10, 2023 |
| Rising Pharma Holdings, Inc. | 1 | tablet | Generic drugs (ANDA) | October 25, 2022 |
| Solubiomix | 1 | solution | New drug applications (NDA) | January 28, 2026 |
| Sunrise Pharmaceutical, Inc. | 1 | tablet | Generic drugs (ANDA) | August 4, 2015 |
| Unit Dose Solutions, Inc. | 1 | tablet | Generic drugs (ANDA) | June 22, 2026 |
| XGen Pharmaceuticals DJB, Inc. | 1 | injection, solution | Generic drugs (ANDA) | November 17, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 54 | 93.1% |
| Injection, solution | 2 | 3.4% |
| Solution | 2 | 3.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 56 | 96.6% |
| Authorized generics (NDA) | 1 | 1.7% |
| New drug applications (NDA) | 1 | 1.7% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.